<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Warm up to Q2 results</title>
	<atom:link href="http://dalaal-street.com/warm-up-to-q2-results/feed/" rel="self" type="application/rss+xml" />
	<link>http://dalaal-street.com/warm-up-to-q2-results/</link>
	<description>Monies and Conversations</description>
	<lastBuildDate>Tue, 27 Jul 2010 15:09:53 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0</generator>
	<item>
		<title>By: Delivering on Q2 expectations &#124; Dalaal-Street</title>
		<link>http://dalaal-street.com/warm-up-to-q2-results/#comment-1186</link>
		<dc:creator>Delivering on Q2 expectations &#124; Dalaal-Street</dc:creator>
		<pubDate>Tue, 03 Nov 2009 13:10:43 +0000</pubDate>
		<guid isPermaLink="false">http://dalaal-street.com/?p=203#comment-1186</guid>
		<description>[...] on this topic.Most of the stocks we have discussed till now have done very well in Q2 nos. In reference to the post on the pre Q2 stock ideas : , both the companies have done [...]</description>
		<content:encoded><![CDATA[<p>[...] on this topic.Most of the stocks we have discussed till now have done very well in Q2 nos. In reference to the post on the pre Q2 stock ideas : , both the companies have done [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Ayush Mittal</title>
		<link>http://dalaal-street.com/warm-up-to-q2-results/#comment-1059</link>
		<dc:creator>Ayush Mittal</dc:creator>
		<pubDate>Thu, 01 Oct 2009 18:16:00 +0000</pubDate>
		<guid isPermaLink="false">http://dalaal-street.com/?p=203#comment-1059</guid>
		<description>Good work, Siddharth.

The past is past. What is making me optimistic are the recent quarters and the potential going ahead.

If one removes the &quot;one time items&quot; from the recent qtr nos, the company is doing very well. 

Lets see their Q2 nos to validate the logic and take further call ;-)

Regards,
Ayush</description>
		<content:encoded><![CDATA[<p>Good work, Siddharth.</p>
<p>The past is past. What is making me optimistic are the recent quarters and the potential going ahead.</p>
<p>If one removes the &#8220;one time items&#8221; from the recent qtr nos, the company is doing very well. </p>
<p>Lets see their Q2 nos to validate the logic and take further call <img src='http://dalaal-street.com/wp-includes/images/smilies/icon_wink.gif' alt=';-)' class='wp-smiley' /> </p>
<p>Regards,<br />
Ayush</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Siddharth Shukla</title>
		<link>http://dalaal-street.com/warm-up-to-q2-results/#comment-1056</link>
		<dc:creator>Siddharth Shukla</dc:creator>
		<pubDate>Thu, 01 Oct 2009 12:38:53 +0000</pubDate>
		<guid isPermaLink="false">http://dalaal-street.com/?p=203#comment-1056</guid>
		<description>Hi ayush,
                  I gave my opinion solely based on the numbers &amp; i haven&#039;t gone through the ARs. First of all looking at the cash flows, they have -ve CFO for past 2 years &amp; -ve FCF for past 5 yrs(not a huge concern if its a fast grower). Gross profit margins are good but Net profit margins have been erratic(-ve in 2k9 ,22% in 2k8, below 10% in 2k7,2k6,2k5) . Coming to asset turns , its been around 0.5 for past 5years, not a gr8 number for a pharma stock i feel. Debt to equity has gone up significantly in 2k9 tough interest covferage looks good barring 2k9. Being a high debt company a look at the ROCE shows poor numbers too except for 2k8. So neither is it a cash generating company &amp; neither is it extremely profitable. I haven&#039;[t looked at the recent quarter numbers tough(i generally don&#039;t look at them due to absence of Balance Sheet &amp; Cash Flow stmt). I have no clue about the oncology space and about the impact of the MNC takeover, my view is solely based on numbers . I welcome your views &amp; ya i am still learning to look at the bigger picture &amp; learning from guys like you , thanks for the advice ... :) . 

Regards,
Siddharth</description>
		<content:encoded><![CDATA[<p>Hi ayush,<br />
                  I gave my opinion solely based on the numbers &amp; i haven&#8217;t gone through the ARs. First of all looking at the cash flows, they have -ve CFO for past 2 years &amp; -ve FCF for past 5 yrs(not a huge concern if its a fast grower). Gross profit margins are good but Net profit margins have been erratic(-ve in 2k9 ,22% in 2k8, below 10% in 2k7,2k6,2k5) . Coming to asset turns , its been around 0.5 for past 5years, not a gr8 number for a pharma stock i feel. Debt to equity has gone up significantly in 2k9 tough interest covferage looks good barring 2k9. Being a high debt company a look at the ROCE shows poor numbers too except for 2k8. So neither is it a cash generating company &amp; neither is it extremely profitable. I haven&#8217;[t looked at the recent quarter numbers tough(i generally don&#8217;t look at them due to absence of Balance Sheet &amp; Cash Flow stmt). I have no clue about the oncology space and about the impact of the MNC takeover, my view is solely based on numbers . I welcome your views &amp; ya i am still learning to look at the bigger picture &amp; learning from guys like you , thanks for the advice &#8230; <img src='http://dalaal-street.com/wp-includes/images/smilies/icon_smile.gif' alt=':)' class='wp-smiley' />  . </p>
<p>Regards,<br />
Siddharth</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Ayush Mittal</title>
		<link>http://dalaal-street.com/warm-up-to-q2-results/#comment-1052</link>
		<dc:creator>Ayush Mittal</dc:creator>
		<pubDate>Thu, 01 Oct 2009 02:31:09 +0000</pubDate>
		<guid isPermaLink="false">http://dalaal-street.com/?p=203#comment-1052</guid>
		<description>Hi Siddharth,

Yes, Ahlcon is cheap if they maintain their nos like in Q1.

Fresenius Kabi is a much better business model with long term growth prospects. Financial are not in a mess - try understanding the bigger picture - After takeover, usually all MNCs do balance sheet clean up and provide for lots of one time expenses. The beauty of this company is :
1. Its in a business which is one of the fastest growing &amp; has very limited big players.
2. Operating margins are very good...close to 25-30%. (Look at Q1)
3. The German co is aggressive and has lined up lots of expansion.

Have a look again, go through their annual report.

Regards,</description>
		<content:encoded><![CDATA[<p>Hi Siddharth,</p>
<p>Yes, Ahlcon is cheap if they maintain their nos like in Q1.</p>
<p>Fresenius Kabi is a much better business model with long term growth prospects. Financial are not in a mess &#8211; try understanding the bigger picture &#8211; After takeover, usually all MNCs do balance sheet clean up and provide for lots of one time expenses. The beauty of this company is :<br />
1. Its in a business which is one of the fastest growing &amp; has very limited big players.<br />
2. Operating margins are very good&#8230;close to 25-30%. (Look at Q1)<br />
3. The German co is aggressive and has lined up lots of expansion.</p>
<p>Have a look again, go through their annual report.</p>
<p>Regards,</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Siddharth Shukla</title>
		<link>http://dalaal-street.com/warm-up-to-q2-results/#comment-1048</link>
		<dc:creator>Siddharth Shukla</dc:creator>
		<pubDate>Wed, 30 Sep 2009 18:40:23 +0000</pubDate>
		<guid isPermaLink="false">http://dalaal-street.com/?p=203#comment-1048</guid>
		<description>Hi ayush,
                 Ahlcon Parentals looks interesting &amp; cheap, i went through the financials &amp; they look good. However i wasn&#039;t quite impressed by Fresenius Kabi, the financials are in a mess &amp; neither is it cheap,is your investment rationale on this one based more on Macro factors??</description>
		<content:encoded><![CDATA[<p>Hi ayush,<br />
                 Ahlcon Parentals looks interesting &amp; cheap, i went through the financials &amp; they look good. However i wasn&#8217;t quite impressed by Fresenius Kabi, the financials are in a mess &amp; neither is it cheap,is your investment rationale on this one based more on Macro factors??</p>
]]></content:encoded>
	</item>
</channel>
</rss>
